Comparison of Simple Blood Lancet(Vitrex®)With DuoTip as Skin Prick Test Devices Among Mite-sensitized Subjects

This study has been completed.
Sponsor:
Information provided by:
Siriraj Hospital
ClinicalTrials.gov Identifier:
NCT01197274
First received: September 8, 2010
Last updated: NA
Last verified: June 2010
History: No changes posted
  Purpose

The purpose of this study is to compare the results skin prick tests using simple blood lancet (Vitrex®) with DuoTips among mite-sensitized subjects.


Condition Intervention Phase
Skin Prick Test
Device: Simple blood lancet
Phase 1
Phase 2

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Comparison of Simple Blood Lancet(Vitrex®)With DuoTip as Devices for Skin Prick Test Among Mite-sensitized Subjects

Further study details as provided by Siriraj Hospital:

Primary Outcome Measures:
  • Wheal and flare reaction to Der p results of skin prick test by simple blood lancet (Vitrex®) [ Time Frame: 15 minutes ] [ Designated as safety issue: No ]

    To determine

    1. Wheal and flare diameter to Der p performed by blood lancet(Vitrex®)compared with DuoTip in mite-sensitized person
    2. Intradevice variability or coefficients of variation of blood lancet compared wtih DuoTip


Secondary Outcome Measures:
  • Determine transfer of allergen by simple blood lancet and Duotips. [ Time Frame: 15 minutes ] [ Designated as safety issue: Yes ]

    To determine

    1. Transfer of allergen(Der p)performed by simple blood lancet(Vitrex®)
    2. Pain assessment by using visual analog scale
    3. Wheal and flare diameter to histamine performed by simple blood lancet(Vitrex®)


Enrollment: 42
Study Start Date: June 2010
Study Completion Date: August 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Mite-sensitized person Device: Simple blood lancet
Skin prick testing with blood lancet and DuoTip is performed on the back of mite-sensitized person. Allergen(Der p)is placed in 1st and 2nd row whereas histamine is placed in 3rd row. Allergen and normal saline are placed alternately in 4th row. Block randomization were allocated subjects into 2 groups; Group1:blood lancet is performed in 1st row and DuoTip in 2nd row. Group2:DuoTip is performed in 1st row and blood lancet in 2nd row. Blood lancet is applied in 3rd and 4th row in all subjects. A technician performed device applications and another technician who is blinded to device performed all readings. Pain was assessed on a scale from 0 to 10 with 0 being no pain and 10 being the worst imaginable pain
Other Name: Vitrex®

Detailed Description:

We intend to compare results of skin prick tests by using simple blood lancet(Vitrex®) and DuoTips in terms of wheal size, variability, transfer of allergen and pain level, among mite-sensitive subjects.

  Eligibility

Ages Eligible for Study:   12 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Individuals who have positive skin prick testing to Der p 10,000 AU/ml (wheal size 3 mm at least)

Criteria

Inclusion Criteria:

  • Who have positive skin prick testing to Der p 10,000 AU/ml (wheal size 3 mm at least)
  • Age 12-60 yrs
  • Written informed consent was obtained from all subjects and their parents

Exclusion Criteria:

  • Who have positive skin prick testing to Der p 10,000 AU/ml above 15 mm.
  • Who have dermographism
  • Who have severe disease eg. severe respiratory disease or severe cardiovascular disease
  • Who have severe eczema
  • Who receive antihistamine, topical steroid within 7 days or ketotifen within 14 days or systemic steroid within 1 month
  • Pregnant women
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01197274

Locations
Thailand
Department of Pediatrics, Siriraj hospital, Mahidol University
Bangkok, Thailand, 10700
Sponsors and Collaborators
Siriraj Hospital
Investigators
Study Director: Professor Pakit Vichyanond, MD Siriraj Hospital, Mahidol University
  More Information

No publications provided

Responsible Party: Professor Pakit Vichyanond, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University
ClinicalTrials.gov Identifier: NCT01197274     History of Changes
Other Study ID Numbers: 186/2553(EC4)
Study First Received: September 8, 2010
Last Updated: September 8, 2010
Health Authority: Thailand: Ethical Committee

Keywords provided by Siriraj Hospital:
allergy
skin prick test
mite sensitivity

ClinicalTrials.gov processed this record on August 26, 2014